AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Metformin And Sitagliptin

9 registrations across 1 African market— 9 active

Markets with Metformin And Sitagliptin

Recent registrations

Brand / ProductMarketHolderStatusExpires
JBCOSE-MAX 500 & 50
Tablets
🇹🇿TanzaniaUNIQUE PHARMACEUTICAL LABORATORIES (A Div. of J. B. Chemicals & Pharmaceuticals Ltd)active
JBCOSE-MAX 1000 & 50
Oral tablet
🇹🇿TanzaniaUNIQUE PHARMACEUTICAL LABORATORIES (A Div. of J. B. Chemicals & Pharmaceuticals Ltd)active
JBCOSE-M
Oral tablet
🇹🇿TanzaniaUNIQUE PHARMACEUTICAL LABORATORIES (A Div. of J. B. Chemicals & Pharmaceuticals Ltd)active
Sitapril M 50/1000
Film Coated Tablet
🇹🇿TanzaniaAjanta Pharma Limitedactive
GLUSIMET 50/1000
Film Coated Tablet
🇹🇿TanzaniaScilife Pharma (Pvt.) Ltd.active
SITAMAC M 500
Film Coated Tablet
🇹🇿TanzaniaMacleods Pharmaceuticals Limitedactive
JBCOSE-MAX 1000 & 100
Tablets
🇹🇿TanzaniaUNIQUE PHARMACEUTICAL LABORATORIES (A Div. of J. B. Chemicals & Pharmaceuticals Ltd)active
DYGLI - M
Film coated tablets
🇹🇿TanzaniaMicro Labs Limitedactive
Sitapril M 50/500
Film Coated Tablet
🇹🇿TanzaniaAjanta Pharma Limitedactive

Metformin And Sitagliptin in Africa — Regulatory Overview

Metformin And Sitagliptin is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.